Nektar Therapeutics (NKTR) Other Working Capital Changes (2010 - 2026)
Nektar Therapeutics (NKTR) posted quarterly Other Working Capital Changes of -$605000.0 for Q1 2021, up 75.9% year-over-year from -$343952.4 in Q1 2020, and down 35.65% quarter-over-quarter from -$446000.0 in Q4 2020.
Nektar Therapeutics (NKTR) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Nektar Therapeutics' Other Working Capital Changes history runs 7 years deep, the most recent figure standing at -$605000.0 for Q1 2021.
- In Q1 2021, Other Working Capital Changes rose 75.9% year-over-year to -$605000.0; the TTM figure through Dec 2021 stood at -$605000.0 (up 89.03% YoY), while the FY2022 annual figure was -$1.1 million, down 75.21% from the prior year.
- Other Working Capital Changes for Q1 2021 stood at -$605000.0, down from -$446000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $9.9 million in Q4 2025, with the low at -$5.6 million in Q1 2023.
- The 5-year median for Other Working Capital Changes is $618000.0 (2025), against an average of $482235.3.
- The sharpest annual moves came in 2019 and 2020: Other Working Capital Changes plunged 61.36% in 2019, then soared 93.72% in 2020.
- Nektar Therapeutics' Other Working Capital Changes stood at -$43.7 million in 2017, then soared by 89.94% to -$4.4 million in 2018, then tumbled by 61.36% to -$7.1 million in 2019, then jumped by 93.72% to -$446000.0 in 2020, then plunged by 35.65% to -$605000.0 in 2021.
- Business Quant data shows NKTR's Other Working Capital Changes at -$605000.0 in Q1 2021, -$446000.0 in Q4 2020, and -$1.3 million in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Nektar Therapeutics | 1.49 Bn | 919.46 Mn | 3.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -949,000.00 |
| Mar 31, 2026 | -949,000.00 |
| Mar 31, 2026 | -949,000.00 |
| Dec 31, 2025 | 9.86 Mn |
| Dec 31, 2025 | 9.86 Mn |
| Dec 31, 2025 | 9.86 Mn |
| Sep 30, 2025 | 618,000.00 |
| Sep 30, 2025 | 618,000.00 |
| Sep 30, 2025 | 618,000.00 |
| Jun 30, 2025 | -985,000.00 |
| Jun 30, 2025 | -985,000.00 |
| Jun 30, 2025 | -985,000.00 |
| Mar 31, 2025 | 5.96 Mn |
| Mar 31, 2025 | 5.96 Mn |
| Mar 31, 2025 | 5.96 Mn |
| Dec 31, 2024 | 2.43 Mn |
| Dec 31, 2024 | 2.43 Mn |
| Dec 31, 2024 | 2.43 Mn |
| Sep 30, 2024 | 3.58 Mn |
| Sep 30, 2024 | 3.58 Mn |